Vimarsana
Biggest News Aggregation in the World

Page 3 - Modular Aseptic Processing News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Modular Aseptic Processing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Modular Aseptic Processing Today - Breaking & Trending Today

Upton applauds Pfizer's continued expansion and investment in Kalamazoo County | WTVB | 1590 AM · 95.5 FM - Vimarsana News

Upton applauds Pfizer's continued expansion and investment in Kalamazoo County | WTVB | 1590 AM · 95.5 FM

WASHINGTON, D.C. (WKZO AM/FM) -- U.S. Representative Fred Upton, R-St. Joseph, on Monday, December 5 released the following statement after Pfizer ann...

Source: wtvbam.com
Senator McCann weighs in on $750 million Pfizer expansion - Vimarsana News

Senator McCann weighs in on $750 million Pfizer expansion

KALAMAZOO, MI (WKZO AM/FM) -- Senator Sean McCann (D-Kalamazoo) issued the following statement Monday, December 5 regarding Pfizer's announcement of a...

Source: wtvbam.com
Pfizer to invest $750 million to expand Portage MI facility and create 300 jobs - Vimarsana News

Pfizer to invest $750 million to expand Portage MI facility and create 300 jobs

KALAMAZOO, MI (WKZO AM/FM) -- Governor Gretchen Whitmer announced on Monday, December 5 that Pfizer Incorporated will be investing $750 million in it'...

Pfizer to Invest $120 Million to Produce COVID-19 Oral Treatment in the U.S. - Vimarsana News

Pfizer to Invest $120 Million to Produce COVID-19 Oral Treatment in the U.S.

NEW YORK -- Pfizer Inc. (NYSE: PFE) announced today that it will further strengthen its commitment to United States manufacturing with a $120 million investment at its Kalamazoo, Michigan, facility, enabling U.S.-based production in support of its CO

US production of Pfizer's Paxlovid to expand - Vimarsana News

US production of Pfizer's Paxlovid to expand

Vaccine-maker Pfizer said Monday that it would invest $120 million at its facility in Michigan, boosting U.S.-based production of the PAXLOVID coronavirus pill.